← All organizations
Highest phase reached
Phase 3
First clinical trial
Dec 1, 2016Last known activity
Jan 20, 2026
Timeline
No events for the selected filters.
Drugs by trial phase (35 distinct, 19 trials)
Phase 3 (18 own, 0 via acquisition)
Phase 2 (7 own, 0 via acquisition)
Other trials (10 own, 0 via acquisition)
Indications
Studied for
Recent trials (20)
- NCT07266168CollaboratorN/AJan 20, 2026
- NCT06968962CollaboratorN/AMay 14, 2025
- NCT06863532CollaboratorN/AMar 30, 2025
- NCT06827587CollaboratorN/AFeb 28, 2025
- NCT06556186CollaboratorN/AOct 1, 2024
- NCT06612814CollaboratorPhase 3Sep 1, 2024
- NCT06520176CollaboratorPhase 3Aug 31, 2024
- NCT06520163CollaboratorPhase 3Aug 31, 2024
- NCT06613113Lead sponsorN/AAug 7, 2024
- NCT06313190CollaboratorPhase 2Apr 5, 2024
- NCT06188650Lead sponsorN/ADec 9, 2023
- NCT06290817CollaboratorPhase 2Mar 30, 2023
- NCT05759546CollaboratorPhase 2Feb 1, 2023
- NCT05759572CollaboratorPhase 2Feb 1, 2023
- NCT04973306CollaboratorPhase 2/Phase 3Jul 31, 2021
Details
- Last known activity
- Jan 20, 2026